Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Nuclear mechanobiology: a brief history and five unresolved questions.
Journal: Nucleus (Austin, Tex.)
Published: August 24, 2026
Prelamin A in an Lmna L648R/L648R Mouse Model Does Not Promote Atherosclerosis or Vascular Smooth Muscle Loss.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 14, 2026
Farnesylated prelamin A induces fibroblast polarity defects in premature aging disorders by inhibiting nesprin-2-SUN2 LINC complex function.
Journal: Journal of cell science
Published: October 03, 2025
Prelamin A Does Not Promote Atherosclerosis or Vascular Smooth Muscle Loss.
Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025
The nucleus activates mechano-responsiveness via FHOD-associated LINC complexes.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Nesprin-2 contains BH3-like motifs that can promote cell death.
Journal: Cell death discovery
Published: November 15, 2024
Apoptosis-induced translocation of nesprin-2 from the nuclear envelope to mitochondria is associated with mitochondrial dysfunction.
Journal: Nucleus (Austin, Tex.)
Published: October 15, 2024
mTOR Inhibition Prolongs Survival and Has Beneficial Effects on Heart Function After Onset of Lamin A/C Gene Mutation Cardiomyopathy in Mice.
Journal: Circulation. Heart failure
Published: April 03, 2024
Prelamin A and ZMPSTE24 in premature and physiological aging.
Journal: Nucleus (Austin, Tex.)
Published: October 27, 2023
Last Updated: 09/26/2026